Company / Income Tax per Share
Adaptimmune Therapeutics PLC Income Tax per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2020-FY2024
Trend
+93.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2020 to $0.00 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of +46.7%.
Improved from $0.00 to $0.00 over the past 2 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +45.5%
- 5-Year CAGR
- +46.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, income tax per share increased 93.8% year-over-year.
- Peak income tax per share was recorded in FY2022.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | +93.8% |
| FY2023 | $0.00 | -49.7% |
| FY2022 | $0.00 | +215.7% |
| FY2021 | $0.00 | +231.7% |
| FY2020 | $0.00 | -33.4% |
| FY2019 | $0.00 | -56.4% |
| FY2018 | $0.00 | -16.7% |
| FY2017 | $0.00 | -49.4% |
| FY2016 | $0.00 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026